0000950170-24-066175.txt : 20240529
0000950170-24-066175.hdr.sgml : 20240529
20240529201132
ACCESSION NUMBER: 0000950170-24-066175
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240528
FILED AS OF DATE: 20240529
DATE AS OF CHANGE: 20240529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coleman Mark
CENTRAL INDEX KEY: 0001658379
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37635
FILM NUMBER: 241000409
MAIL ADDRESS:
STREET 1: 25 BROADWAY
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axsome Therapeutics, Inc.
CENTRAL INDEX KEY: 0001579428
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 454241907
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: (212) 332-3241
MAIL ADDRESS:
STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
4
1
ownership.xml
4
X0508
4
2024-05-28
0001579428
Axsome Therapeutics, Inc.
AXSM
0001658379
Coleman Mark
C/O AXSOME THERAPEUTICS, INC.
ONE WORLD TRADE CENTER, 22ND FLOOR
NEW YORK
NY
10007
true
false
false
false
true
Common Stock
2024-05-28
4
S
false
5249
75.2095
D
19848
D
Common Stock
2024-05-29
4
S
false
5248
75.1396
D
14600
D
Such transaction was pursuant to a pre-approved 10b5-1 plan.
Represents the sale of underlying shares of previously exercised stock options.
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $75.00 and $75.88.
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $75.00 and $75.90.
/s/ Herriot Tabuteau, M.D., Attorney-in-Fact
2024-05-29